Pharmaceutical standards : including tolerances and methods of analysis

LDR 01431namZa2200337ZZZ4500
001 101721930
003 MiAaHDL
005 20160909000000.0
006 m d
007 cr bn ---auaua
008 810313s1935####dcu###########000#0#eng##
010 ‡a 36023641
035 ‡asdr-umn9929485320001701
035 ‡a(OCoLC)4014140
035 ‡a(MnU)notisABH6530
035 ‡z(MnU)Aleph000061705
040 ‡aDLC ‡cMNU-B ‡dMNU-B ‡dMnU
050 0 0 ‡aRS189 ‡b.C6 1935
082 0 ‡a614.35
110 2 ‡aCombined Pharmaceutical Contact Committee.
245 1 0 ‡aPharmaceutical standards : ‡bincluding tolerances and methods of analysis / ‡cprepared by the Combined Pharmaceutical Contact Committee, American Drug Manufacturers Association and American Pharmaceutical Manufacturers Association, with the cooperation of the Food and Drug Administration, U. S. Department of Agriculture.
250 ‡aRev. ed.
260 ‡aWashington, D. C. : ‡bAmerican Drug Manufacturers Association; ‡aNew York : ‡bAmerican Pharmaceutical Manufacturers Association, ‡c1935.
300 ‡a1 volume ; ‡c21 cm
336 ‡atext ‡btxt ‡2rdacontent
337 ‡aunmediated ‡bn ‡2rdamedia
338 ‡avolume ‡bnc ‡2rdacarrier
500 ‡aLoose-leaf.
538 ‡aMode of access: Internet.
650 0 ‡aDrugs ‡xAnalysis.
650 0 ‡aDrug adulteration.
650 0 ‡aDrugs ‡xStandards.
710 1 ‡aUnited States. ‡bFood and Drug Administration.
710 2 ‡aAmerican Pharmaceutical Manufacturers' Association.
710 2 ‡aAmerican Drug Manufacturers Association.
CID ‡a101721930
DAT 0 ‡a20160607155423.0 ‡b20160909000000.0
DAT 1 ‡a20160910090530.0 ‡b2024-10-02T18:22:17Z
DAT 2 ‡a2024-10-02T17:30:01Z ‡b2023-04-27T20:00:02Z
CAT ‡aSDR-UMN ‡dEX LIBRIS - ALMA ‡lprepare.pl-004-006
FMT ‡aBK
HOL ‡0sdr-umn9929485320001701 ‡aumn ‡bSDR ‡cUMN ‡pumn.31951000136291l ‡sUMN ‡19929485320001701
974 ‡bUMN ‡cUMN ‡d20241002 ‡sgoogle ‡uumn.31951000136291l ‡y1935 ‡rpdus ‡qren